All In MedTech

Device Trial Radar · NCT03390257

Study to Evaluate the Safety and Initial Effectiveness of the Sinusway™ for Endoscopy of Sinuses in Conjunction With BSD

Safety and Effectiveness Evaluation of the Sinusway™ Device for Endoscopy of the Nasal Cavity and Paranasal Sinuses in Conjunction With Sinus Balloon Dilation

Last checked: Nov 20, 2026Latest source record: Dec 8, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

14

Actual

Start

Apr 25, 2017

Primary completion

Mar 21, 2018

Study completion May 2, 2019

Sponsor

Lead sponsor
3NT Medical Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Jan 4, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

3NT flexible endoscope is a single-use disposable handheld endoscope that provides a means to visualize the nasal cavity and paranasal sinus space and deliver irrigation to treat the sinus ostia and spaces within the paranasal sinus cavities for diagnostic and therapeutic procedures

Conditions

  • Sinusitis

Interventions

  • 3NT flexible endoscopeDevice

    The nasal anatomy will be accessed and viewed with the device during Balloon Sinus Dilation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Adverse Device EffectsTime frame: 4 hours

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • SF Otolaryngology

    San Francisco, California

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.